Clinical Trial Update: Reversal of Complete Heart Block With Aminophylline in Inferior Wall Myocardial Infarction Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating aminophylline to reverse complete heart block in patients with inferior wall myocardial infarction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complete Heart Block
• Inferior Wall Myocardial Infarction

Drugs mentioned

• Aminophylline (aminophylline)

Snippet

Sponsor: National Institute of Cardiovascular Diseases, Pakistan | Conditions: Complete Heart Block, Inferior Wall Myocardial Infarction | Phase 4 | Status: WITHDRAWN